Top Banner
Current and Emerging Advances in Mantle Cell Lymphoma
41

Current and Emerging Advances in Mantle Cell Lymphoma

Feb 22, 2016

Download

Documents

Amber

Current and Emerging Advances in Mantle Cell Lymphoma. Mantle Cell Lymphoma Atypical Cases. Mantle Cell Lymphoma Current Treatment Paradigm. Rituximab Maintenance vs ASCT E1405 Study. Mantle Cell Lymphoma Older Patient With Comorbidities. - PowerPoint PPT Presentation
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Page 1: Current and Emerging Advances in Mantle Cell Lymphoma

Current and Emerging Advances in Mantle Cell Lymphoma

Page 2: Current and Emerging Advances in Mantle Cell Lymphoma
Page 3: Current and Emerging Advances in Mantle Cell Lymphoma
Page 4: Current and Emerging Advances in Mantle Cell Lymphoma
Page 5: Current and Emerging Advances in Mantle Cell Lymphoma
Page 6: Current and Emerging Advances in Mantle Cell Lymphoma

Mantle Cell LymphomaAtypical Cases

Page 7: Current and Emerging Advances in Mantle Cell Lymphoma
Page 8: Current and Emerging Advances in Mantle Cell Lymphoma
Page 9: Current and Emerging Advances in Mantle Cell Lymphoma
Page 10: Current and Emerging Advances in Mantle Cell Lymphoma
Page 11: Current and Emerging Advances in Mantle Cell Lymphoma
Page 12: Current and Emerging Advances in Mantle Cell Lymphoma

Mantle Cell LymphomaCurrent Treatment Paradigm

Page 13: Current and Emerging Advances in Mantle Cell Lymphoma
Page 14: Current and Emerging Advances in Mantle Cell Lymphoma
Page 15: Current and Emerging Advances in Mantle Cell Lymphoma
Page 16: Current and Emerging Advances in Mantle Cell Lymphoma
Page 17: Current and Emerging Advances in Mantle Cell Lymphoma
Page 18: Current and Emerging Advances in Mantle Cell Lymphoma
Page 19: Current and Emerging Advances in Mantle Cell Lymphoma

Rituximab Maintenance vs ASCT E1405 Study

Page 20: Current and Emerging Advances in Mantle Cell Lymphoma

Mantle Cell LymphomaOlder Patient With Comorbidities

Page 21: Current and Emerging Advances in Mantle Cell Lymphoma
Page 22: Current and Emerging Advances in Mantle Cell Lymphoma

Bendamustine with RituximabRelapsed/Refractory Disease

Page 23: Current and Emerging Advances in Mantle Cell Lymphoma

Mantle Cell LymphomaRelapsed/Refractory Disease

Page 24: Current and Emerging Advances in Mantle Cell Lymphoma
Page 25: Current and Emerging Advances in Mantle Cell Lymphoma
Page 26: Current and Emerging Advances in Mantle Cell Lymphoma
Page 27: Current and Emerging Advances in Mantle Cell Lymphoma
Page 28: Current and Emerging Advances in Mantle Cell Lymphoma
Page 29: Current and Emerging Advances in Mantle Cell Lymphoma
Page 30: Current and Emerging Advances in Mantle Cell Lymphoma
Page 31: Current and Emerging Advances in Mantle Cell Lymphoma
Page 32: Current and Emerging Advances in Mantle Cell Lymphoma

Abbreviations

Page 33: Current and Emerging Advances in Mantle Cell Lymphoma

Abbreviations (cont)

Page 34: Current and Emerging Advances in Mantle Cell Lymphoma

References

Page 35: Current and Emerging Advances in Mantle Cell Lymphoma

References (cont)

Page 36: Current and Emerging Advances in Mantle Cell Lymphoma

References (cont)

Page 37: Current and Emerging Advances in Mantle Cell Lymphoma

References (cont)

Page 38: Current and Emerging Advances in Mantle Cell Lymphoma

References (cont)

Page 39: Current and Emerging Advances in Mantle Cell Lymphoma

References (cont)

Page 40: Current and Emerging Advances in Mantle Cell Lymphoma

References (cont)

Page 41: Current and Emerging Advances in Mantle Cell Lymphoma

References (cont)